Skip to content
10-Q

Quarterly Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-19-000013

← back to feed
Filed
Jan 9, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 19, 2018 9.7M sh
Short Term Debt Q3 2018 · Sep 30, 2018 $3.96K
Current Liabilities Q3 2018 · Sep 30, 2018 $181.32K
Current Liabilities Q3 2018 · Dec 31, 2017 $134.23K
Total Liabilities Q3 2018 · Sep 30, 2018 $185.28K
Total Liabilities Q3 2018 · Dec 31, 2017 $134.23K
Current Assets Q3 2018 · Sep 30, 2018 $6K
Current Assets Q3 2018 · Dec 31, 2017 $4.69K
Total Assets Q3 2018 · Sep 30, 2018 $6K
Total Assets Q3 2018 · Dec 31, 2017 $4.69K
Sga Expense Q3 2018 · Sep 30, 2018 $1.44K
Sga Expense Q3 2018 · Sep 30, 2018 $5.91K
Sga Expense Q3 2018 · Sep 30, 2017 $1.5K
Sga Expense Q3 2018 · Sep 30, 2017 $2.73K
Gross Profit Q3 2018 · Sep 30, 2018 −$166
Gross Profit Q3 2018 · Sep 30, 2018 −$2.09K
Gross Profit Q3 2018 · Sep 30, 2017 $800
Gross Profit Q3 2018 · Sep 30, 2017 $800
Cost Of Revenue Q3 2018 · Sep 30, 2018 $1.86K
Cost Of Revenue Q3 2018 · Sep 30, 2018 $8.26K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $3.52K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $3.52K
Revenue Q3 2018 · Sep 30, 2018 $1.69K
Revenue Q3 2018 · Sep 30, 2018 $6.16K
Revenue Q3 2018 · Sep 30, 2017 $4.32K
Revenue Q3 2018 · Sep 30, 2017 $4.32K
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$20.23K
Cash And Equivalents Q3 2018 · Sep 30, 2017 $392
Net Income Q3 2018 · Sep 30, 2017 −$16.8K
Net Income Q3 2018 · Sep 30, 2017 −$22.29K
Operating Income Q3 2018 · Sep 30, 2017 −$15.9K
Operating Income Q3 2018 · Sep 30, 2017 −$21.38K